CARS2 Hypermethylation Is a Risk Factor for Heart Failure: A Project Baseline Health Substudy
Authors:
- Jessica A. ReganJRJessica A. Regan
- Jordan FranklinJFJordan Franklin
- Kalyani KottililKKKalyani Kottilil
- Nicholas CauwenberghsNCNicholas Cauwenberghs
- Kenneth W. MahaffeyKMKenneth W. Mahaffey
- Pamela S. DouglasPDPamela S. Douglas
- Fatima RodriguezFRFatima Rodriguez
- Adrian F. HernandezAHAdrian F. Hernandez
- Svati H. ShahSSSvati H. Shah
- Lydia Coulter KweeLKLydia Coulter Kwee
- on behalf of the Project Baseline Health Study GroupOGon behalf of the Project Baseline Health Study Group
- 1 October 2025
- journal article
- Published by Wolters Kluwer Health in Circulation: Genomic and Precision Medicine
- Vol. 18 (5) , e005073
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Accelerated Epigenetic Aging Is Associated With Multiple Cardiometabolic, Hematologic, and Renal Abnormalities: A Project Baseline Health SubstudyCirculation: Genomic and Precision Medicine, 2023
- Clinical and Echocardiographic Diversity Associated With Physical Fitness in the Project Baseline Health Study: Implications for Heart Failure StagingJournal of Cardiac Failure, 2023
- DNA methylation reprograms cardiac metabolic gene expression in end-stage human heart failureAmerican Journal of Physiology-Heart and Circulatory Physiology, 2019
- A Guide for a Cardiovascular Genomics Biorepository: the CATHGEN ExperienceJournal of Cardiovascular Translational Research, 2015
- Mutations in the mitochondrial cysteinyl-tRNA synthase gene, CARS2, lead to a severe epileptic encephalopathy and complex movement disorderJournal of Medical Genetics, 2015